Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.

Article  CAS  PubMed  Google Scholar 

Unisa S, Jagannath P, Dhir V, Khandelwal C, Sarangi L, Roy TK. Population-based study to estimate prevalence and determine risk factors of gallbladder diseases in the rural Gangetic basin of North India. HPB (Oxford). 2011;13:117–25. https://doi.org/10.1111/j.1477-2574.2010.00255.x.

Article  PubMed  Google Scholar 

Rout N, Hota SK, Dash S, Samantaray S, Mallik RN, Agrawal O. Diagnostic utility of ultrasound-guided fine-needle aspiration cytology in gall bladder lesions: an experience from a tertiary care cancer center in Eastern India. J Cytol. 2021;38:145–50. https://doi.org/10.4103/JOC.JOC_166_20.

Article  PubMed  PubMed Central  Google Scholar 

Roa JC, García P, Kapoor VK, Maithel SK, Javle M, Koshiol J. Gallbladder cancer Nat Rev Dis Primers. 2022;8:69. https://doi.org/10.1038/s41572-022-00398-y.

Article  PubMed  Google Scholar 

Canale M, Monti M, Rapposelli IG, et al. Molecular targets and emerging therapies for advanced gallbladder cancer. Cancers (Basel). 2021;13:5671. https://doi.org/10.3390/cancers13225671.

Article  CAS  PubMed  Google Scholar 

Barreto SG, Haga H, Shukla PJ. Hormones and gallbladder cancer in women. Indian J Gastroenterol. 2009;28:126–30. https://doi.org/10.1007/s12664-009-0046-8.

Article  PubMed  Google Scholar 

Gabbi C, Kim HJ, Barros R, Korach-Andrè M, Warner M, Gustafsson JA. Estrogen-dependent gallbladder carcinogenesis in LXRbeta-/- female mice. Proc Natl Acad Sci U S A. 2010;107:14763–8. https://doi.org/10.1073/pnas.1009483107.

Article  PubMed  PubMed Central  Google Scholar 

Srivastava A, Sharma KL, Srivastava N, Misra S, Mittal B. Significant role of estrogen and progesterone receptor sequence variants in gallbladder cancer predisposition: a multi-analytical strategy. PLoS ONE. 2012;7: e40162. https://doi.org/10.1371/journal.pone.0040162.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hammond ME, Hayes DF, Dowsett M, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol. 2010;28:2784–95. https://doi.org/10.1200/JCO.2009.25.6529.

Article  PubMed  PubMed Central  Google Scholar 

Hryciuk B, Pęksa R, Bieńkowski M, et al. Expression of female sex hormone receptors, connective tissue growth factor and HER2 in gallbladder cancer. Sci Rep. 1871;2020:10. https://doi.org/10.1038/s41598-020-58777-y.

Article  CAS  Google Scholar 

Cohen DA, Dabbs DJ, Cooper KL, et al. Interobserver agreement among pathologists for semiquantitative hormone receptor scoring in breast carcinoma. Am J Clin Pathol. 2012;138:796–802. https://doi.org/10.1309/AJCP6DKRND5CKVDD.

Article  CAS  PubMed  Google Scholar 

Sachidananda S, Krishnan A, Janani K, et al. Characteristics of gallbladder cancer in South India. Indian J Surg Oncol. 2012;3(3):228–30. https://doi.org/10.1007/s13193-012-0150-6.

Article  PubMed  PubMed Central  Google Scholar 

Saranga Bharathi R, Singh R, Gupta R, et al. Female sex hormone receptors in gallbladder cancer. J Gastrointest Cancer. 2015;46(2):143–8. https://doi.org/10.1007/s12029-015-9698-z.

Article  CAS  PubMed  Google Scholar 

Nakamura S, Muro H, Suzuki S. Estrogen and progesterone receptors in gallbladder cancer. Jpn J Surg. 1989;19:189–94. https://doi.org/10.1007/BF02471584.

Article  CAS  PubMed  Google Scholar 

Yamamoto M, Nakajo S, Tahara E. Immunohistochemical analysis of estrogen receptors in human gallbladder. Acta Pathol Jpn. 1990;40:14–21. https://doi.org/10.1111/j.1440-1827.1990.tb01524.x.

Article  CAS  PubMed  Google Scholar 

Ko CY, Schmit P, Cheng L, Thompson JE. Estrogen receptors in gallbladder cancer: detection by an improved immunohistochemical assay. Am Surg. 1995,61:930–3. https://pubmed.ncbi.nlm.nih.gov/7668471/

Malik IA, Abbas Z, Shamsi Z, et al. Immuno-histochemical analysis of estrogen receptors on the malignant gallbladder tissue. J Pak Med Assoc. 1998,48:123–6. https://pubmed.ncbi.nlm.nih.gov/9813971/

Sumi K, Matsuyama S, Kitajima Y, Miyazaki K. Loss of estrogen receptor beta expression at cancer front correlates with tumor progression and poor prognosis of gallbladder cancer. Oncol Rep. 2004,12:979–84. https://pubmed.ncbi.nlm.nih.gov/15492781/

Baskaran V, Vij U, Sahni P, Tandon RK, Nundy S. Do the progesterone receptors have a role to play in gallbladder cancer? Int J Gastrointest Cancer. 2005;35:61–8. https://doi.org/10.1385/IJGC:35:1:061.

Article  CAS  PubMed  Google Scholar 

Shukla PJ, Barreto SG, Gupta P, et al. Is there a role for estrogen and progesterone receptors in gall bladder cancer? HPB (Oxford). 2007;9:285–8. https://doi.org/10.1080/13651820701481489.

Article  CAS  PubMed  Google Scholar 

Albores-Saavedra J, Henson DE, Moran-Portela D, Lino-Silva S. Cribriform carcinoma of the gallbladder: a clinicopathologic study of 7 cases. Am J Surg Pathol. 2008;32:1694–8. https://doi.org/10.1097/PAS.0b013e3181706237.

Article  PubMed  Google Scholar 

Park JS, Jung WH, Kim JK, et al. Estrogen receptor alpha, estrogen receptor beta, and progesterone receptor as possible prognostic factor in radically resected gallbladder carcinoma. J Surg Res. 2009;152:104–10. https://doi.org/10.1016/j.jss.2008.01.032.

Article  CAS  PubMed  Google Scholar 

Gupta P, Agarwal A, Gupta V, Singh PK, Pantola C, Amit S. Expression and clinicopathological significance of estrogen and progesterone receptors in gallbladder cancer. Gastrointest Cancer Res. 2012,5:41–7. https://pubmed.ncbi.nlm.nih.gov/22690257/

Zhang LQ, Xu XS, Wan Y, et al. Prognostic implications of estrogen receptor 1 and vascular endothelial growth factor A expression in primary gallbladder carcinoma. World J Gastroenterol. 2015;21:1243–50. https://doi.org/10.3748/wjg.v21.i4.1243.

Article  PubMed  PubMed Central  Google Scholar 

Wang L, Yang M, Guo X, et al. Estrogen-related receptor-α promotes gallbladder cancer development by enhancing the transcription of Nectin-4. Cancer Sci. 2020;111(5):1514–27. https://doi.org/10.1111/cas.14344.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Beltjens F, Molly D, Bertaut A, et al. ER-/PR+ breast cancer: A distinct entity, which is morphologically and molecularly close to triple-negative breast cancer. Int J Cancer. 2021;149:200–13. https://doi.org/10.1002/ijc.33539.

Article  CAS  PubMed  Google Scholar 

Welsh AW, Lannin DR, Young GS, et al. Cytoplasmic estrogen receptor in breast cancer. Clin Cancer Res. 2012;18:118–26. https://doi.org/10.1158/1078-0432.CCR-11-1236.

Article  CAS  PubMed  Google Scholar 

Ebata A, Suzuki T, Shoji-Harada N, et al. Immunolocalization of cytoplasmic ER in ER-negative breast carcinoma as a potent favorable prognostic predictor. Acta Histochem Cytochem. 2023;56:59–66. https://doi.org/10.1267/ahc.23-00016.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Piasecka D, Składanowski AC, Kordek R, Romańska HM, Sądej R. Aspekty regulacji aktywności receptora progesteronu (PR) - znaczenie w progresji raka gruczołu piersiowego [Aspects of progesterone receptor (PR) activity regulation - impact on breast cancer progression]. Postepy Biochem. 2015,61:198–6. https://pubmed.ncbi.nlm.nih.gov/26689013/

Cuzick J, Sestak I, Cawthorn S, et al. Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial. Lancet Oncol. 2015;16(1):67–75. https://doi.org/10.1016/S1470-2045(14)71171-4.

Article  CAS  PubMed  PubMed Central  Google Scholar